Business
Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market
NEW YORK, September 16, 2025--Oscar Health, Inc. ("Oscar") (NYSE: OSCR) today announced the pricing of its offering of $355,000,000 aggregate principal amount of 2.25% convertible senior subordinated notes due 2030 (the "notes") in a private offering (the "Offering") to qualified investors.1 The offering size was increased from the previously announced offering size of $350,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on September 18, 20
About this update from Oscar Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/2a52b8e53e126a0775c13fbdb03b860a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EUl5iyy0N1Br3loghUY5JQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2a52b8e53e126a0775c13fbdb03b860a","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sg3NSLBzkn0SWicCjLN7NQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/2a52b8e53e126a0775c13fbdb03b860a","width":1024,"height":512}},"lazy":false},{"type":"text","content":"- Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as well as the potential extension of enhanced premium tax credits- Attractive cost of capital compared to other financing alternatives- Expect to use a part of proceeds to purchase a call option on Oscar stock that offsets any share dilution, capped at a 100% premium to the stock price at pricing","length":452,"tagName":"p"},{"type":"text","content":"NEW YORK, September 16, 2025--(BUSINESS WIRE)--Oscar Health, Inc. ("Oscar") (NYSE: OSCR) today announced the pricing of its offering of $355,000,000 aggregate principal amount of 2.25% convertible senior subordinated notes due 2030 (the "notes") in a private offering (the "Offering") to qualified investors.1 The offering size was increased from the previously announced offering size of $350,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on September 18, 2025 subject to customary closing conditions. Oscar also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $55,000,000 aggregate principal amount of notes.","length":837,"tagName":"p"},{"type":"text","content":"Oscar estimates that the net proceeds to Oscar from the Offering will be approximately $342.5 million (or approximately $395.8 million if the initial purchasers fully exercise their option to purchase additional notes), after d...